H Igari1, A Watanabe, T Sato. 1. Division of Control and Treatment of Infectious Diseases, Chiba University Hospital, Chiba, Japan. igari@faculty.chiba-u.jp
Abstract
SETTING: University medical school in Japan. OBJECTIVE: To clarify the influence of prior intradermal purified protein derivative (PPD) injection on QuantiFERON-TB Gold (QFT-G). DESIGN: Ninety-seven sixth-year university medical students aged 20-29 years concurrently underwent QFT-G and tuberculin skin test (TST). The first negative QFT-G and the first TST <15 mm were followed by a second QFT-G one month later. RESULTS: Five of the 97 (5%) subjects tested positive for the first QFT-G. Thirty-three underwent a second QFT-G, five of whom (15%) turned positive, demonstrating the booster phenomenon of QFT-G. CONCLUSIONS: Prior intradermal PPD injection may boost QFT-G. Further studies of the diagnostic significance and immunological mechanisms of this phenomenon are needed. For clinical application, especially during contact screening, QFT-G should be evaluated while keeping in mind the possible influence of prior PPD intradermal injection.
SETTING: University medical school in Japan. OBJECTIVE: To clarify the influence of prior intradermal purified protein derivative (PPD) injection on QuantiFERON-TB Gold (QFT-G). DESIGN: Ninety-seven sixth-year university medical students aged 20-29 years concurrently underwent QFT-G and tuberculin skin test (TST). The first negative QFT-G and the first TST <15 mm were followed by a second QFT-G one month later. RESULTS: Five of the 97 (5%) subjects tested positive for the first QFT-G. Thirty-three underwent a second QFT-G, five of whom (15%) turned positive, demonstrating the booster phenomenon of QFT-G. CONCLUSIONS: Prior intradermal PPD injection may boost QFT-G. Further studies of the diagnostic significance and immunological mechanisms of this phenomenon are needed. For clinical application, especially during contact screening, QFT-G should be evaluated while keeping in mind the possible influence of prior PPD intradermal injection.
Authors: Jason R Andrews; Mark Hatherill; Hassan Mahomed; Willem A Hanekom; Monica Campo; Thomas R Hawn; Robin Wood; Thomas J Scriba Journal: Am J Respir Crit Care Med Date: 2015-03-01 Impact factor: 21.405
Authors: Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei Journal: Clin Microbiol Rev Date: 2014-01 Impact factor: 26.132
Authors: M Pai; R Joshi; S Dogra; A A Zwerling; D Gajalakshmi; K Goswami; M V R Reddy; A Kalantri; P C Hill; D Menzies; P C Hopewell Journal: Int J Tuberc Lung Dis Date: 2009-01 Impact factor: 2.373
Authors: Maria Fernanda Reis Gavazzoni Dias; Fred Bernardes Filho; Maria Victória Quaresma; Leninha Valério do Nascimento; José Augusto da Costa Nery; David Rubem Azulay Journal: An Bras Dermatol Date: 2014 Nov-Dec Impact factor: 1.896
Authors: Rosemary E Weir; Patricia Gorak-Stolinska; Sian Floyd; Maeve K Lalor; Sally Stenson; Keith Branson; Rose Blitz; Anne Ben-Smith; Paul E M Fine; Hazel M Dockrell Journal: BMC Infect Dis Date: 2008-01-25 Impact factor: 3.090
Authors: Ifedayo M O Adetifa; Moses D Lugos; Abdulrahman Hammond; David Jeffries; Simon Donkor; Richard A Adegbola; Philip C Hill Journal: BMC Infect Dis Date: 2007-10-25 Impact factor: 3.090
Authors: Matthew K O'Shea; Thomas E Fletcher; Nicholas J Beeching; Martin Dedicoat; David Spence; Helen McShane; Adam F Cunningham; Duncan Wilson Journal: PLoS One Date: 2014-05-09 Impact factor: 3.240